Management of status Epilepticus and critical care Seizures

Current Clinical Neurology

Volumn , Issue , 2010, Pages 355-422

  Varelas, Panayiotis N ^a,b   Spanaki, Marianna V ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Antiepileptic medications; Intensive care unit; Nonconvulsive status epilepticus; Seizures; Status epilepticus

Indexed keywords

ALUMINUM HYDROXIDE; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CLOBAZAM; CLOMETHIAZOLE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; GABAPENTIN; HARKOSERIDE; ISOFLURANE; KETAMINE; LIDOCAINE; LORAZEPAM; MIDAZOLAM; PARALDEHYDE; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PLACEBO; PROPOFOL; ROCURONIUM; SUXAMETHONIUM; THIOPENTAL; UNINDEXED DRUG; VALPROIC ACID; VECURONIUM;

ADD ON THERAPY; AIRWAY; ANTICONVULSANT ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; ATAXIA; ATELECTASIS; BLOOD CLOTTING DISORDER; BLOOD DISEASE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BRADYCARDIA; BRAIN ATROPHY; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; BRAIN PROTECTION; BRAIN SURGERY; BREATHING; CARDIOPULMONARY DEPRESSION; CARDIOPULMONARY INSUFFICIENCY; CARDIORESPIRATORY DEPRRESSION; CENTRAL NERVOUS SYSTEM DISEASE; CIRCULATION; CLINICAL FEATURE; COMA; COMBINATION CHEMOTHERAPY; COMPLEX PARTIAL SEIZURE; COMPLEX PARTIAL STATUS EPILEPTICUS; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DROWSINESS; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; ELECTROLYTE DISTURBANCE; ENDOTRACHEAL INTUBATION; EPILEPTIC STATE; FATIGUE; FLUID OVERLOAD; FOCAL EPILEPSY; FOCAL STATUS EPILEPTICUS; GRAND MAL SEIZURE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPERLIPIDEMIA; HYPEROSMOLALITY; HYPOTENSION; HYPOTHERMIA; INCIDENCE; INFECTION; INJECTION SITE; INJECTION SITE REACTION; INJECTION SITE SPASM; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LIQUID; LIVER DYSFUNCTION; LIVER FAILURE; LIVER TOXICITY; LOADING DRUG DOSE; MAINTENANCE THERAPY; MEGALOBLASTIC ANEMIA; METABOLIC ACIDOSIS; METABOLIC ENCEPHALOPATHY; MICROEMBOLISM; MONOTHERAPY; MORBIDITY; MORTALITY; MYOCARDIAL DEPRESSION; MYOCLONUS SEIZURE; NAUSEA; NEUROPATHY; NEUTROPENIA; NEWBORN INTENSIVE CARE; NONHUMAN; NYSTAGMUS; OUTCOME ASSESSMENT; PANCREATITIS; PARALYTIC ILEUS; PATHOPHYSIOLOGY; PHLEBITIS; PRIORITY JOURNAL; QT PROLONGATION; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; RESPIRATION DEPRESSION; RHABDOMYOLYSIS; SEDATION; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; TONIC CLONIC SEIZURE; TONIC SEIZURE; TRAINING; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; VEIN THROMBOSIS; VOMITING;

EID: 79953701656     PISSN: 15590585     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-532-3_15     Document Type: Article

References (291)

1. Holtkamp M (2007) The anaesthetic and intensive care of status epilepticus. Curr Opin Neurol 20:188-193
2. Walker MC (2003) Status epilepticus on the intensive care unit. J Neurol 250: 401-406
3. Walker MC, Smith SJ, Shorvon SD (1995) The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations. Anaesthesia 50:130-135
4. Walker MC, Howard RS, Smith SJ, Miller DH, Shorvon SD, Hirsch NP (1996) Diagnosis and treatment of status epilepticus on a neurological intensive care unit. QJM 89:913-920
5. Alldredge BK, Gelb AM, Isaacs SM et al (2001) A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 345:631-637
6. Gastaut H (1983) Classification of status epilepticus. Adv Neurol 34:15-35
7. Treatment of convulsive status epilepticus (1993) Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 270:854-859
8. Bleck TP (1991) Convulsive disorders: status epilepticus. Clin Neuropharmacol 14:191-198
9. Ramsay RE (1993) Treatment of status epilepticus. Epilepsia 34:S71-S81
10. Treiman DM, Meyers PD, Walton NY et al (1998) A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 339:792-798
11. Lowenstein DH (1999) Status epilepticus: an overview of the clinical problem. Epilepsia 40(Suppl 1):S3-S8 discussion S21-S22
12. Husain AM, Mebust KA, Radtke RA (1999) Generalized periodic epileptiform discharges: etiologies, relationship to status epilepticus, and prognosis. J Clin Neurophysiol 16:51-58
13. Krumholz A (1999) Epidemiology and evidence for morbidity of nonconvulsive status epilepticus. J Clin Neurophysiol 16:314-322 discussion 353
14. Kaplan PW (1999) Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol. 16:341-352
15. Walker MC (2001) Diagnosis and treatment of nonconvulsive status epilepticus. CNS Drugs 15:931-939
16. Young GB, Gilbert JJ, Zochodne DW (1990) The significance of myoclonic status epilepticus in postanoxic coma. Neurology 40:1843-1848
17. Privitera M, Hoffman M, Moore JL, Jester D (1994) EEG detection of nontonicclonic status epilepticus in patients with altered consciousness. Epilepsy Res 18:155-166
18. Hauser WA (1990) Status epilepticus: epidemiologic considerations. Neurology 40:9-13
19. Shorvon S (1994) The outcome of tonic-clonic status epilepticus. Curr Opin Neurol 7:93-95
20. DeLorenzo RJ, Hauser WA, Towne AR et al (1996) A prospective, populationbased epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46:1029-1035
21. Bleck TP, Smith MC, Pierre-Louis SJ, Jares JJ, Murray J, Hansen CA (1993) Neurologic complications of critical medical illnesses. Crit Care Med 21:98-103
22. Lowenstein DH, Alldredge BK (1993) Status epilepticus at an urban public hospital in the 1980s. Neurology 43:483-488
23. Barry E, Hauser WA (1994) Status epilepticus and antiepileptic medication levels. Neurology 44:47-50
24. Dunne JW, Summers QA, Stewart-Wynne EG (1987) Non-convulsive status epilepticus: a prospective study in an adult general hospital. Q J Med 62:117-126
25. Celesia GG (1976) Modern concepts of status epilepticus. JAMA 235:1571-1574
26. DeLorenzo RJ, Waterhouse EJ, Towne AR et al (1998) Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 39:833-840
27. Privitera MD, Strawsburg RH (1994) Electroencephalographic monitoring in the emergency department. Emerg Med Clin North Am 12:1089-1100
28. Wijdicks EF, Sharbrough FW (1993) New-onset seizures in critically ill patients. Neurology 43:1042-1044
29. Towne AR, Waterhouse EJ, Boggs JG et al (2000) Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 54:340-345
30. Drislane FW, Lopez MR, Blum AS, Schomer DL (2008) Detection and treatment of refractory status epilepticus in the intensive care unit. J Clin Neurophysiol 25:181-186
31. Jordan KG (1999) Continuous EEG monitoring in the neuroscience intensive care unit and emergency department. J Clin Neurophysiol 16:14-39
32. Varelas PN, Hacein-Bey L, Hether T, Terranova B, Spanaki MV (2004) Emergent electroencephalogram in the intensive care unit: indications and diagnostic yield. Clin EEG Neurosci 35:173-180
33. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA (1998) Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 50:735-741
34. Jaitly R, Sgro JA, Towne AR, Ko D, DeLorenzo RJ (1997) Prognostic value of EEG monitoring after status epilepticus: a prospective adult study. J Clin Neurophysiol 14:326-334
35. Towne AR, Pellock JM, Ko D, DeLorenzo RJ (1994) Determinants of mortality in status epilepticus. Epilepsia 35:27-34
36. Jordan KG (1999) Nonconvulsive status epilepticus in acute brain injury. J Clin Neurophysiol 16:332-340 discussion 353
37. Shneker BF, Fountain NB (2003) Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology 61:1066-1073
38. Kaplan PW (1999) Intravenous valproate treatment of generalized nonconvulsive status epilepticus. Clin Electroencephalogr 30:1-4
39. Lothman EW (1998) Biological consequences of repeated seizures. In: Engel J, Pedley TA (eds) Epilepsy: a comprehensive textbook, vol 1. Lippincott-Raven, Philadelphia-New York, pp 481-497
40. Loscher W (2007) Mechanisms of drug resistance in status epilepticus. Epilepsia 48(Suppl 8):74-77
41. Bankstahl JP, Loscher W (2008) Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus. Epilepsy Res 82(1):70-85
42. Iannetti P, Spalice A, Parisi P (2005) Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia 46:967-969
43. Meldrum BS, Brierley JB (1973) Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol 28:10-17
44. Meldrum BS, Vigouroux RA, Brierley JB (1973) Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 29:82-87
45. Aminoff MJ, Simon RP (1980) Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med 69:657-666
46. Meldrum BS, Horton RW (1973) Physiology of status epilepticus in primates. Arch Neurol 28:1-9
47. Boggs JG, Painter JA, DeLorenzo RJ (1993) Analysis of electrocardiographic changes in status epilepticus. Epilepsy Res 14:87-94
48. Treiman DM (1995) Electroclinical features of status epilepticus. J Clin Neurophysiol 12:343-362
49. Parry T, Hirsch N (1992) Psychogenic seizures after general anaesthesia. Anaesthesia 47:534
50. Leppik IE (1993) Status epilepticus. In: Wyllie E (ed) The treatment of epilepsy: principles and practice. Lea and Febige, Philadelphia, pp 678-685
51. Varelas PN, Spanaki MV, Hacein-Bey L, Hether T, Terranova B (2003) Emergent EEG: indications and diagnostic yield. Neurology 61:702-704
52. Holtkamp M, Othman J, Buchheim K, Meierkord H (2006) Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting. Neurology 66:1727-1729
53. Walsh GO, Delgado-Escueta AV (1993) Status epilepticus. Neurol Clin 11:835-856
54. Treiman DM, Walton NY, Kendrick C (1990) A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 5:49-60
55. Thomas P (1997) Status epilepticus: indications for emergency EEG. Neurophysiol Clin 27:398-405
56. Kaplan PW (1996) Nonconvulsive status epilepticus in the emergency room. Epilepsia 37:643-650
57. Pakalnis A, Drake ME Jr, Phillips B (1991) Neuropsychiatric aspects of psychogenic status epilepticus. Neurology 41:1104-1106
58. Vespa P (2005) Continuous EEG monitoring for the detection of seizures in traumatic brain injury, infarction, and intracerebral hemorrhage: "to detect and protect". J Clin Neurophysiol 22:99-106
59. Niedermeyer E, Lopes Da Silva F (eds) (1999) Electroencephalography: basic principles, clinical applications and related fields. Lippincott-Williams, Baltimore
60. Jumao-as A, Brenner RP (1990) Myoclonic status epilepticus: a clinical and electroencephalographic study. Neurology 40:1199-1202
61. Granner MA, Lee SI (1994) Nonconvulsive status epilepticus: EEG analysis in a large series. Epilepsia 35:42-47
62. Kaplan PW (2007) EEG criteria for nonconvulsive status epilepticus. Epilepsia 48(Suppl 8):39-41
63. Fountain NB, Waldman WA (2001) Effects of benzodiazepines on triphasic waves: implications for nonconvulsive status epilepticus. J Clin Neurophysiol 18:345-352
64. Fagan KJ, Lee SI (1990) Prolonged confusion following convulsions due to generalized nonconvulsive status epilepticus. Neurology 40:1689-1694
65. Hirsch LJ, Claassen J, Mayer SA, Emerson RG (2004) Stimulus-induced rhythmic, periodic, or ictal discharges (SIRPIDs): a common EEG phenomenon in the critically ill. Epilepsia 45:109-123
66. Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA (1997) Shortterm mortality after a first episode of status epilepticus. Epilepsia 38:1344-1349
67. DeLorenzo RJ, Towne AR, Pellock JM, Ko D (1992) Status epilepticus in children, adults, and the elderly. Epilepsia 33(Suppl 4):S15-S25
68. DeLorenzo RJ, Garnett LK, Towne AR et al (1999) Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia 40:164-169
69. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF (2002) Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 59:205-210
70. Krumholz A, Sung GY, Fisher RS, Barry E, Bergey GK, Grattan LM (1995) Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology 45:1499-1504
71. Guaranha MS, Garzon E, Buchpiguel CA, Tazima S, Yacubian EM, Sakamoto AC (2005) Hyperventilation revisited: physiological effects and efficacy on focal seizure activation in the era of video-EEG monitoring. Epilepsia 46:69-75
72. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F (1983) Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 74:540-544
73. Tomlinson FH, Anderson RE, Meyer FB (1993) Effect of arterial blood pressure and serum glucose on brain intracellular pH, cerebral and cortical blood flow during status epilepticus in the white New Zealand rabbit. Epilepsy Res 14:123-137
74. Simon RP (1985) Physiologic consequences of status epilepticus. Epilepsia 26(Suppl 1):S58-S66
75. Holtkamp M, Othman J, Buchheim K, Masuhr F, Schielke E, Meierkord H (2005) A "malignant" variant of status epilepticus. Arch Neurol 62:1428-1431
76. Shorvon S (2000) Emergency treatment of epilepsy. In: Shorvon S (ed) Handbook of epilepsy treatment. Blackwell Science, Malden, MA, pp 173-194
77. Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B (1983) Doubleblind study of lorazepam and diazepam in status epilepticus. JAMA 249:1452-1454
78. Shaner DM, McCurdy SA, Herring MO, Gabor AJ (1988) Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 38:202-207
79. Lowenstein DH, Alldredge BK (1998) Status epilepticus. N Engl J Med 338: 970-976
80. Lowenstein DH (2003) Treatment options for status epilepticus. Curr Opin Pharmacol 3:6-11
81. Bleck TP (2002) Refractory status epilepticus in 2001. Arch Neurol 59:188-189
82. Holtkamp M, Masuhr F, Harms L, Einhaupl KM, Meierkord H, Buchheim K (2003) The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists. J Neurol Neurosurg Psychiatry 74:1095-1099
83. Zbinden G, Randall LO (1967) Pharmacology of benzodiazepines: laboratory and clinical correlations. Adv Pharmacol 5:213-291
84. Meldrum BS, Chapman AG (1986) Benzodiazepine receptors and their relationship to the treatment of epilepsy. Epilepsia 27(Suppl 1):S3-S13
85. Amrein R, Hetzel W (1991) Pharmacology of drugs frequently used in ICUs: midazolam and flumazenil. Intensive Care Med 17(Suppl 1):S1-S10
86. Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ (1985) Midazolam: pharmacology and uses. Anesthesiology 62:310-324
87. Bell DS (1969) Dangers of treatment of status epilepticus with diazepam. Br Med J 1:159-161
88. Shorvon S (2000) Antiepileptic drugs. In: Shorvon S (ed) Handbook of epilepsy treatment. Blackwell Science, Oxford, UK, pp 85-172
89. Cereghino JJ, Mitchell WG, Murphy J, Kriel RL, Rosenfeld WE, Trevathan E (1998) Treating repetitive seizures with a rectal diazepam formulation: a randomized study. The North American Diastat Study Group. Neurology 51:1274-1282
90. Dreifuss FE, Rosman NP, Cloyd JC et al (1998) A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med 338:1869-1875
91. Appleton R, Sweeney A, Choonara I, Robson J, Molyneux E (1995) Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Dev Med Child Neurol 37:682-688
92. Cock HR, Schapira AH (2002) A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. QJM 95:225-231
93. Dirksen MS, Vree TB, Driessen JJ (1987) Clinical pharmacokinetics of long-term infusion of midazolam in critically ill patients-preliminary results. Anaesth Intensive Care 15:440-444
94. Towne AR, DeLorenzo RJ (1999) Use of intramuscular midazolam for status epilepticus. J Emerg Med 17:323-328
95. Wroblewski BA, Joseph AB (1992) The use of intramuscular midazolam for acute seizure cessation or behavioral emergencies in patients with traumatic brain injury. Clin Neuropharmacol 15:44-49
96. Galdames D, Aguilera M, Fabres L (1997) Midazolam in the treatment of status epilepticus and frequent seizures in adults. Epilepsia 38:12
97. Chamberlain JM, Altieri MA, Futterman C, Young GM, Ochsenschlager DW, Waisman Y (1997) A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care 13:92-94
98. Mayhue FE (1988) IM midazolam for status epilepticus in the emergency department. Ann Emerg Med 17:643-645
99. McDonagh TJ, Jelinek GA, Galvin GM (1992) Intramuscular midazolam rapidly terminates seizures in children and adults. Emerg Med 4:77-81
100. Ulvi H, Yoldas T, Mungen B, Yigiter R (2002) Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus. Neurol Sci 23:177-182
101. Varelas PN (2008) How I treat status epilepticus in the Neuro-ICU. Neurocrit Care 9:153-157
102. Treiman DM (1989) Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus. Epilepsia 30(Suppl 2):S4-S10
103. Jamerson BD, Dukes GE, Brouwer KL, Donn KH, Messenheimer JA, Powell JR (1994) Venous irritation related to intravenous administration of phenytoin versus fosphenytoin. Pharmacotherapy 14:47-52
104. Jones GL, Wimbish GH, McIntosh WE (1983) Phenytoin: basic and clinical pharmacology. Med Res Rev 3:383-434
105. Chapman MG, Smith M, Hirsch NP (2001) Status epilepticus. Anaesthesia 56: 648-659
106. Browne TR, Kugler AR, Eldon MA (1996) Pharmacology and pharmacokinetics of fosphenytoin. Neurology 46:S3-S7
107. Boucher BA (1996) Fosphenytoin: a novel phenytoin prodrug. Pharmacotherapy 16:777-791
108. Payne TA, Bleck TP (1997) Status epilepticus. Crit Care Clin 13:17-38
109. DeToledo JC, Lowe MR, Rabinstein A, Villaviza N (2001) Cardiac arrest after fast intravenous infusion of phenytoin mistaken for fosphenytoin. Epilepsia 42:288
110. Fischer JH, Patel TV, Fischer PA (2003) Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet 42:33-58
111. Marchetti A, Magar R, Fischer J, Sloan E, Fischer P (1996) A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx) versus intravenous phenytoin (Dilantin) in hospital emergency departments. Clin Ther 18:953-966
112. Coplin WM, Rhoney DH, Rebuck JA, Clements EA, Cochran MS, O'Neil BJ (2002) Randomized evaluation of adverse events and length-of-stay with routine emergency department use of phenytoin or fosphenytoin. Neurol Res 24:842-848
113. Villarreal HJ, Wilder BJ, Willmore LJ, Bauman AW, Hammond EJ, Bruni J (1978) Effect of valproic acid on spike and wave discharges in patients with absence seizures. Neurology 28:886-891
114. Wilder BJ, Ramsay RE, Murphy JV, Karas BJ, Marquardt K, Hammond EJ (1983) Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures. Neurology 33:1474-1476
115. Beydoun A, Sackellares JC, Shu V (1997) Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group. Neurology 48:182-188
116. Penry JK, Dean JC (1988) Valproate monotherapy in partial seizures. Am J Med 84:14-16
117. Bourgeois BFD (1995) Valproic: clinical use. In: Levy RH, Mattson RH, Meldrum BS (eds) Antiepileptic drugs. Raven Press, New York
118. Willmore LJ, Wilder BJ, Bruni J, Villarreal HJ (1978) Effect of valproic acid on hepatic function. Neurology 28:961-964
119. Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA, Menander KB (1987) Valproic acid hepatic fatalities: a retrospective review. Neurology 37:379-385
120. Gerstner T, Teich M, Bell N et al (2006) Valproate-associated coagulopathies are frequent and variable in children. Epilepsia 47:1136-1143
121. Hodges BM, Mazur JE (2001) Intravenous valproate in status epilepticus. Ann Pharmacother 35:1465-1470
122. Zaccara G, Messori A, Moroni F (1988) Clinical pharmacokinetics of valproic acid-1988. Clin Pharmacokinet 15:367-389
123. Ramsay RE, Uthman B, Leppik IE et al (1997) The tolerability and safety of valproate sodium injection given as an intravenous infusion. J Epilepsy 10:187-193
124. Devinsky O, Leppik I, Willmore LJ et al (1995) Safety of intravenous valproate. Ann Neurol 38:670-674
125. Venkataraman V, Wheless JW (1999) Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 35:147-153
126. Uberall MA, Trollmann R, Wunsiedler U, Wenzel D (2000) Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology 54:2188-2189
127. Sinha S, Naritoku DK (2000) Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 55:722-724
128. Chez MG, Hammer MS, Loeffel M, Nowinski C, Bagan BT (1999) Clinical experience of three pediatric and one adult case of spike-and-wave status epilepticus treated with injectable valproic acid. J Child Neurol 14:239-242
129. Alehan FK, Morton LD, Pellock JM (1999) Treatment of absence status with intravenous valproate. Neurology 52:889-890
130. Giroud M, Gras D, Escousse A (1993) Use of injectable valproic in status epilepticus. Drug Invest 5:154-159
131. Yu KT, Mills S, Thompson N, Cunanan C (2003) Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia 44:724-726
132. Martin ED, Pozo MA (2003) Valproate suppresses status epilepticus induced by 4-aminopyridine in CA1 hippocampus region. Epilepsia 44:1375-1379
133. Price DJ (1989) Intravenous valproate: experience in neurosurgery. Royal Society of Medicine Service, International Congress and Symposium Series, vol. 152. Royal Society of Medicine Services Limited, London
134. Peters CN, Pohlmann-Eden B (1999) Efficacy and safety of intravenous valproate in status epilepticus. Epilepsia 40:149-150
135. Sheth RD, Gidal BE (2000) Intravenous valproic acid for myoclonic status epilepticus. Neurology 54:1201
136. Naritoku DK, Sinha S (2001) Outcome of status epilepticus treated with intravenous valproate. Neurology 56:A235
137. Limdi NA, Shimpi AV, Faught E, Gomez CR, Burneo JG (2005) Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 64:353-355
138. Misra UK, Kalita J, Patel R (2006) Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 67:340-342
139. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N (2007) Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 16:527-532
140. Gilad R, Izkovitz N, Dabby R et al (2008) Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand 118(5):296-300
141. Olsen KB, Tauboll E, Gjerstad L (2007) Valproate is an effective, well-tolerated drug for treatment of status epilepticus/serial attacks in adults. Acta Neurol Scand Suppl 187:51-54
142. Meierkord H, Boon P, Engelsen B et al (2006) EFNS guideline on the management of status epilepticus. Eur J Neurol 13:445-450
143. Kalviainen R (2007) Status epilepticus treatment guidelines. Epilepsia 48(Suppl 8): 99-102
144. Serrano-Castro PJ, Casado-Chocan JL, Mercade-Cerda JM et al (2005) The Andalusia Epilepsy Society's Guide to Epilepsy Therapy 2005: III. Antiepileptic therapy in special situations. Rev Neurol 40:683-695
145. van Rijckevorsel K, Boon P, Hauman H et al (2006) Standards of care for non-convulsive status epilepticus: Belgian consensus recommendations. Acta Neurol Belg 106:117-124
146. van Rijckevorsel K, Boon P, Hauman H et al (2005) Standards of care for adults with convulsive status epilepticus: Belgian consensus recommendations. Acta Neurol Belg 105:111-118
147. Minicucci F, Muscas G, Perucca E, Capovilla G, Vigevano F, Tinuper P (2006) Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy. Epilepsia 47(Suppl 5):9-15
148. Parviainen I, Uusaro A, Kalviainen R, Kaukanen E, Mervaala E, Ruokonen E (2002) High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology 59:1249-1251
149. Devlin EG, Clarke RS, Mirakhur RK, McNeill TA (1994) Effect of four i.v. induction agents on T-lymphocyte proliferations to PHA in vitro. Br J Anaesth 73:315-317
150. Magnuson B, Hatton J, Williams S, Loan T (1999) Tolerance and efficacy of enteral nutrition for neurosurgical patients on pentobarbital coma. Nutr Clin Practice 14:131-134
151. Olson KR, Pond SM, Verrier ED, Federle M (1984) Intestinal infarction complicating phenobarbital overdose. Arch Intern Med 144:407-408
152. Rashkin MC, Youngs C, Penovich P (1987) Pentobarbital treatment of refractory status epilepticus. Neurology 37:500-503
153. Krishnamurthy KB, Drislane FW (1999) Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia 40:759-762
154. Claassen J, Hirsch LJ, Emerson RG, Mayer SA (2002) Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 43:146-153
155. Rossetti AO, Logroscino G, Bromfield EB (2005) Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 62:1698-1702
156. Bergey GK (2006) Refractory status epilepticus: Is EEG burst suppression an appropriate treatment target during drug-induced coma? What is the Holy Grail? Epilepsy Curr 6:119-120
157. Rossetti AO (2007) Which anesthetic should be used in the treatment of refractory status epilepticus? Epilepsia 48(Suppl 8):52-55
158. Treiman DM (1999) Convulsive status epilepticus. Curr Treat Options Neurol 1:359-369
159. Krishnamurthy KB, Drislane FW (1996) Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 37:863-867
160. Mirski MA, Williams MA, Hanley DF (1995) Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. Crit Care Med 23:400-404
161. Miller MA, Forni A, Yogaratnam D (2008) Propylene glycol-induced lactic acidosis in a patient receiving continuous infusion pentobarbital. Ann Pharmacother 42:1502-1506
162. Stecker MM, Kramer TH, Raps EC, O'Meeghan R, Dulaney E, Skaar DJ (1998) Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 39:18-26
163. Walder B, Tramer MR, Seeck M (2002) Seizure-like phenomena and propofol: a systematic review. Neurology 58:1327-1332
164. Hodkinson BP, Frith RW, Mee EW (1987) Propofol and the electroencephalogram. Lancet 2:1518
165. Hufnagel A, Elger CE, Nadstawek J, Stoeckel H, Bocker DK (1990) Specific response of the epileptic focus to anesthesia with propofol. J Epilepsy 3:37-45
166. Hanna JP, Ramundo ML (1998) Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology 50:301-303
167. Strickland RA, Murray MJ (1995) Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: is there a relationship? Crit Care Med 23:405-409
168. Perrier ND, Baerga-Varela Y, Murray MJ (2000) Death related to propofol use in an adult patient. Crit Care Med 28:3071-3074
169. Cremer OL, Moons KG, Bouman EA, Kruijswijk JE, de Smet AM, Kalkman CJ (2001) Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 357:117-118
170. Smith H, Sinson G, Varelas P (2009) Vasopressors and propofol infusion syndrome in severe head trauma. Neurocrit Care 10(2):166-172
171. Prasad A, Worrall BB, Bertram EH, Bleck TP (2001) Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 42:380-386
172. Parviainen I, Uusaro A, Kalviainen R, Mervaala E, Ruokonen E (2006) Propofol in the treatment of refractory status epilepticus. Intensive Care Med 32:1075-1079
173. Walton NY, Treiman DM (1991) Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam. Brain Res 553:97-104
174. Rice AC, DeLorenzo RJ (1999) N-methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam. Neuroscience 93:117-123
175. Borris DJ, Bertram EH, Kapur J (2000) Ketamine controls prolonged status epilepticus. Epilepsy Res 42:117-122
176. Sheth RD, Gidal BE (1998) Refractory status epilepticus: response to ketamine. Neurology 51:1765-1766
177. Pruss H, Holtkamp M (2008) Ketamine successfully terminates malignant status epilepticus. Epilepsy Res 82(2-3):219-222
178. Ubogu EE, Sagar SM, Lerner AJ, Maddux BN, Suarez JI, Werz MA (2003) Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy Behav 4:70-75
179. Kofke WA, Bloom MJ, Van Cott A, Brenner RP (1997) Electrographic tachyphylaxis to etomidate and ketamine used for refractory status epilepticus controlled with isoflurane. J Neurosurg Anesthesiol 9:269-272
180. Kofke WA, Young RS, Davis P et al (1989) Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology 71:653-659
181. Mirsattari SM, Sharpe MD, Young GB (2004) Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 61:1254-1259
182. Aggarwal P, Wali JP (1993) Lidocaine in refractory status epilepticus: a forgotten drug in the emergency department. Am J Emerg Med 11:243-244
183. Shorvon S (2001) The management of status epilepticus. J Neurol Neurosurg Psychiatry 70:II22-II27
184. Duncan JS (2002) The promise of new antiepileptic drugs. Br J Clin Pharmacol 53:123-131
185. Perucca E (1999) The clinical pharmacokinetics of the new antiepileptic drugs. Epilepsia 40(Suppl 9):S7-S13
186. Cramer JA, Fisher R, Ben-Menachem E, French J, Mattson RH (1999) New antiepileptic drugs: comparison of key clinical trials. Epilepsia 40:590-600
187. White HS (1999) Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia 40(Suppl 5):S2-S10
188. Mazarati AM, Baldwin RA, Sofia RD, Wasterain CG (2000) Felbamate in experimental model of status epilepticus. Epilepsia 41:123-127
189. Chronopoulos A, Stafstrom C, Thurber S, Hyde P, Mikati M, Holmes GL (1993) Neuroprotective effect of felbamate after kainic acid-induced status epilepticus. Epilepsia 34:359-366
190. Barrueto F Jr, Green J, Howland MA, Hoffman RS, Nelson LS (2002) Gabapentin withdrawal presenting as status epilepticus. J Toxicol Clin Toxicol 40:925-928
191. Striano P, Coppola A, Madia F et al (2007) Life-threatening status epilepticus following gabapentin administration in a patient with benign adult familial myoclonic epilepsy. Epilepsia 48:1995-1998
192. Pandey CK, Singh N, Bose N, Sahay S (2003) Gabapentin and propofol for treatment of status epilepticus in acute intermittent porphyria. J Postgrad Med 49:285
193. Bhatia R, Vibha D, Srivastava MV, Prasad K, Tripathi M, Bhushan Singh M (2008) Use of propofol anesthesia and adjunctive treatment with levetiracetam and gabapentin in managing status epilepticus in a patient of acute intermittent porphyria. Epilepsia 49:934-936
194. Halonen T, Nissinen J, Pitkanen A (2001) Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat. Epilepsy Res 46:205-223
195. Walton NY, Jaing Q, Hyun B, Treiman DM (1996) Lamotrigine vs. phenytoin for treatment of status epilepticus: comparison in an experimental model. Epilepsy Res 24:19-28
196. Pisani F, Gallitto G, Di Perri R (1991) Could lamotrigine be useful in status epilepticus? A case report. J Neurol Neurosurg Psychiatry 54:845-846
197. Trinka E, Dilitz E, Unterberger I et al (2002) Non convulsive status epilepticus after replacement of valproate with lamotrigine. J Neurol 249:1417-1422
198. Guerrini R, Belmonte A, Parmeggiani L, Perucca E (1999) Myoclonic status epilepticus following high-dosage lamotrigine therapy. Brain Dev 21:420-424
199. Braga AJ, Chidley K (2007) Self-poisoning with lamotrigine and pregabalin. Anaesthesia 62:524-527
200. Dinnerstein E, Jobst BC, Williamson PD (2007) Lamotrigine intoxication provoking status epilepticus in an adult with localization-related epilepsy. Arch Neurol 64:1344-1346
201. Lynch BA, Lambeng N, Nocka K et al (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 101:9861-9866
202. Niespodziany I, Klitgaard H, Margineanu DG (2001) Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices. Neurosci Lett 306:5-8
203. Rigo JM, Hans G, Nguyen L et al (2002) The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 136:659-672
204. Szaflarski JP, Meckler JM, Szaflarski M, Shutter LA, Privitera MD, Yates SL (2007) Levetiracetam use in critically ill patients. Neurocrit Care 7:140-147
205. Rossetti AO, Bromfield EB (2006) Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 8:651-654
206. Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G (2007) Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res 73:238-244
207. Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN (2006) The use of levetiracetam in refractory status epilepticus. Seizure 15:137-141
208. Ramael S, Daoust A, Otoul C et al (2006) Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 47:1128-1135
209. Ruegg S, Naegelin Y, Hardmeier M, Winkler DT, Marsch S, Fuhr P (2008) Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav 12:477-480
210. Knake S, Gruener J, Hattemer K et al (2008) Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry 79:588-589
211. Takano K, Tanaka T, Fujita T, Nakai H, Yonemasu Y (1995) Zonisamide: electrophysiological and metabolic changes in kainic acid-induced limbic seizures in rats. Epilepsia 36:644-648
212. Frisch C, Kudin AP, Elger CE, Kunz WS, Helmstaedter C (2007) Amelioration of water maze performance deficits by topiramate applied during pilocarpineinduced status epilepticus is negatively dose-dependent. Epilepsy Res 73: 173-180
213. Niebauer M, Gruenthal M (1999) Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res 837:263-269
214. Towne AR, Garnett LK, Waterhouse EJ, Morton LD, DeLorenzo RJ (2003) The use of topiramate in refractory status epilepticus. Neurology 60:332-334
215. Bensalem MK, Fakhoury TA (2003) Topiramate and status epilepticus: report of three cases. Epilepsy Behav 4:757-760
216. Reuber M, Evans J, Bamford JM (2002) Topiramate in drug-resistant complex partial status epilepticus. Eur J Neurol 9:111-112
217. Perry MS, Holt PJ, Sladky JT (2006) Topiramate loading for refractory status epilepticus in children. Epilepsia 47:1070-1071
218. Mangano S, Cusumano L, Fontana A (2003) Non-convulsive status epilepticus associated with tiagabine in a pediatric patient. Brain Dev 25:518-521
219. Kellinghaus C, Dziewas R, Ludemann P (2002) Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure 11:243-249
220. Skardoutsou A, Voudris KA, Vagiakou EA (2003) Non-convulsive status epilepticus associated with tiagabine therapy in children. Seizure 12:599-601
221. Ostrovskiy D, Spanaki MV, Morris GL 3rd (2002) Tiagabine overdose can induce convulsive status epilepticus. Epilepsia 43:773-774
222. Shinnar S, Berg AT, Treiman DM et al (2001) Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons. Epilepsia 42: 372-379
223. Loscher W, Honack D (1997) Intravenous carbamazepine: comparison of different parenteral formulations in a mouse model of convulsive status epilepticus. Epilepsia 38:106-113
224. Graves NM, Kriel RL, Jones-Saete C, Cloyd JC (1985) Relative bioavailability of rectally administered carbamazepine suspension in humans. Epilepsia 26: 429-433
225. So EL, Ruggles KH, Cascino GD, Ahmann PA, Weatherford KW (1994) Seizure exacerbation and status epilepticus related to carbamazepine-10, 11-epoxide. Ann Neurol 35:743-746
226. Callahan DJ, Noetzel MJ (1992) Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. Neurology 42:2198-2201
227. Osorio I, Reed RC, Peltzer JN (2000) Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine. Epilepsia 41:887-894
228. Marini C, Parmeggiani L, Masi G, D'Arcangelo G, Guerrini R (2005) Nonconvulsive status epilepticus precipitated by carbamazepine presenting as dissociative and affective disorders in adolescents. J Child Neurol 20:693-696
229. Ono A, Yano T, Sawaishi Y, Komatsu K, Takada G (2001) A case of carbamazepine intoxication with alpha coma and status epilepticus. No To Hattatsu 33:528-532
230. Spiller HA, Carlisle RD (2002) Status epilepticus after massive carbamazepine overdose. J Toxicol Clin Toxicol 40:81-90
231. Sillanpaa M, Pihlaja T (1988) Oxcarbazepine (GP 47 680) in the treatment of intractable seizures. Acta Paediatr Hung 29:359-364
232. Knake S, Klein KM, Hattemer K et al (2007) Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain. Epilepsy Behav 11:471-473
233. Doty P, Rudd GD, Stoehr T, Thomas D (2007) Lacosamide. Neurotherapeutics 4:145-148
234. Biton V, Rosenfeld WE, Whitesides J, Fountain NB, Vaiciene N, Rudd GD (2008) Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia 49:418-424
235. Kellinghaus C, Berning S, Besselmann M (2009) Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav 14(2):429-431
236. Vastola EF, Homan R, Rosen A (1969) Inhibition of focal seizures by moderate hypothermia. A clinical and experimental study. Arch Neurol 20:430-439
237. Lundgren J, Smith ML, Blennow G, Siesjo BK (1994) Hyperthermia aggravates and hypothermia ameliorates epileptic brain damage. Exp Brain Res 99:43-55
238. Liu Z, Gatt A, Mikati M, Holmes GL (1993) Effect of temperature on kainic acid-induced seizures. Brain Res 631:51-58
239. Maeda T, Hashizume K, Tanaka T (1999) Effect of hypothermia on kainic acid-induced limbic seizures: an electroencephalographic and 14C-deoxyglucose autoradiographic study. Brain Res 818:228-235
240. Kim JH, Kim SH, Yoo SK, Kim JY, Nam YT (1998) The effects of mild hypothermia on thiopental-induced electroencephalogram burst suppression. J Neurosurg Anesthesiol 10:137-141
241. Orlowski JP, Erenberg G, Lueders H, Cruse RP (1984) Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med 12:367-372
242. Corry JJ, Dhar R, Murphy T, Diringer MN (2008) Hypothermia for refractory status epilepticus. Neurocrit Care 9:189-197
243. Ma X, Liporace J, O'Connor MJ, Sperling MR (2001) Neurosurgical treatment of medically intractable status epilepticus. Epilepsy Res 46:33-38
244. Ng YT, Kim HL, Wheless JW (2003) Successful neurosurgical treatment of childhood complex partial status epilepticus with focal resection. Epilepsia 44:468-471
245. Duane DC, Ng YT, Rekate HL, Chung S, Bodensteiner JB, Kerrigan JF (2004) Treatment of refractory status epilepticus with hemispherectomy. Epilepsia 45:1001-1004
246. Ng YT, Kerrigan JF, Rekate HL (2006) Neurosurgical treatment of status epilepticus. J Neurosurg 105:378-381
247. Schrader LM, Stern JM, Wilson CL et al (2006) Low frequency electrical stimulation through subdural electrodes in a case of refractory status epilepticus. Clin Neurophysiol 117:781-788
248. Patwardhan RV, Dellabadia J Jr, Rashidi M, Grier L, Nanda A (2005) Control of refractory status epilepticus precipitated by anticonvulsant withdrawal using left vagal nerve stimulation: a case report. Surg Neurol 64:170-173
249. Carrasco Gonzalez MD, Palomar M, Rovira R (1997) Electroconvulsive therapy for status epilepticus. Ann Intern Med 127:247-248
250. Fountain NB (2000) Status epilepticus: risk factors and complications. Epilepsia 41(Suppl 2):S23-S30
251. Sasahira M, Lowry T, Simon RP (1997) Neuronal injury in experimental status epilepticus in the rat: role of acidosis. Neurosci Lett 224:177-180
252. Evans MC, Meldrum BS (1984) Regional brain glucose metabolism in chemicallyinduced seizures in the rat. Brain Res 297:235-245
253. Swan JH, Meldrum BS, Simon RP (1986) Hyperglycemia does not augment neuronal damage in experimental status epilepticus. Neurology 36:1351-1354
254. Kreisman NR, Gauthier-Lewis ML, Conklin SG, Voss NF, Barbee RW (1993) Cardiac output and regional hemodynamics during recurrent seizures in rats. Brain Res 626:295-302
255. Darnell JC, Jay SJ (1982) Recurrent postictal pulmonary edema: a case report and review of the literature. Epilepsia 23:71-83
256. Terrence CF, Rao GR, Perper JA (1981) Neurogenic pulmonary edema in unexpected, unexplained death of epileptic patients. Ann Neurol 9:458-464
257. Cockerell OC, Rothwell J, Thompson PD, Marsden CD, Shorvon SD (1996) Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK. Brain 119(Pt 2):393-407
258. Thomas P, Borg M, Suisse G, Chatel M (1995) Opercular myoclonic-anarthric status epilepticus. Epilepsia 36:281-289
259. Manford M, Shorvon SD (1992) Prolonged sensory or visceral symptoms: an under-diagnosed form of non-convulsive focal (simple partial) status epilepticus. J Neurol Neurosurg Psychiatry 55:714-716
260. Wells CR, Labar DR, Solomon GE (1992) Aphasia as the sole manifestation of simple partial status epilepticus. Epilepsia 33:84-87
261. Walker MC, Smith SJ, Sisodiya SM, Shorvon SD (1995) Case of simple partial status epilepticus in occipital lobe epilepsy misdiagnosed as migraine: clinical, electrophysiological, and magnetic resonance imaging characteristics. Epilepsia 36:1233-1236
262. Huang CW, Hsieh YJ, Pai MC, Tsai JJ, Huang CC (2005) Nonketotic hyperglycemiarelated epilepsia partialis continua with ictal unilateral parietal hyperperfusion. Epilepsia 46:1843-1844
263. Mut M, Schiff D, Dalmau J (2005) Paraneoplastic recurrent multifocal encephalitis presenting with epilepsia partialis continua. J Neurooncol 72:63-66
264. Wroe SJ, Ellershaw JE, Whittaker JA, Richens A (1987) Focal motor status epilepticus following treatment with azlocillin and cefotaxime. Med Toxicol 2:233-234
265. Schomer DL (1993) Focal status epilepticus and epilepsia partialis continua in adults and children. Epilepsia 34(Suppl 1):S29-S36
266. Drislane FW, Blum AS, Schomer DL (1999) Focal status epilepticus: clinical features and significance of different EEG patterns. Epilepsia 40:1254-1260
267. Aktekin B, Dogan EA, Oguz Y, Karaali K (2006) Epilepsia partialis continua in a patient with Behcet's disease. Clin Neurol Neurosurg 108:392-395
268. Aydin-Ozemir Z, Tuzun E, Baykan B et al (2006) Autoimmune thyroid encephalopathy presenting with epilepsia partialis continua. Clin EEG Neurosci 37: 204-209
269. Kato Y, Nakazato Y, Tamura N, Tomioka R, Takahashi Y, Shimazu K (2007) Autoimmune encephalitis with anti-glutamate receptor antibody presenting as epilepsia partialis continua and action myoclonus: a case report. Rinsho Shinkeigaku 47:429-433
270. Scholtes FB, Renier WO, Meinardi H (1996) Simple partial status epilepticus: causes, treatment, and outcome in 47 patients. J Neurol Neurosurg Psychiatry 61:90-92
271. Brandt L, Saveland H, Ljunggren B, Andersson KE (1988) Control of epilepsy partialis continuans with intravenous nimodipine. Report of two cases. J Neurosurg 69:949-950
272. Rotenberg A, Bae EH, Takeoka M, Tormos JM, Schachter SC, Pascual-Leone A (2009) Repetitive transcranial magnetic stimulation in the treatment of epilepsia partialis continua. Epilepsy Behav 14:253-257
273. Meierkord H, Holtkamp M (2007) Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 6:329-339
274. Treiman DM, Walker MC (2006) Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus. Epilepsy Res 68(Suppl 1):S77-S82
275. Litt B, Wityk RJ, Hertz SH et al (1998) Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 39:1194-1202
276. Crouteau D, Shevell M, Rosenblatt B, Dilenge ME, Andermann F (1998) Treatment of absence status in the Lennox-Gastaut syndrome with propofol. Neurology 51:315-316
277. Lothman EW, Bertram EH, Bekenstein JW, Perlin JB (1989) Self-sustaining limbic status epilepticus induced by 'continuous' hippocampal stimulation: electrographic and behavioral characteristics. Epilepsy Res 3:107-119
278. Scholtes FB, Renier WO, Meinardi H (1996) Non-convulsive status epilepticus: causes, treatment, and outcome in 65 patients. J Neurol Neurosurg Psychiatry 61:93-95
279. Farooq MU, Naravetla B, Majid A, Gupta R, Pysh JJ, Kassab MY (2007) IV levetiracetam in the management of non-convulsive status epilepticus. Neurocrit Care 7:36-39
280. Brain Resuscitation Clinical Trial I Study Group (1986) Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 314:397-403
281. Celesia GG, Grigg MM, Ross E (1988) Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies. Arch Neurol 45:781-784
282. Krumholz A, Stern BJ, Weiss HD (1988) Outcome from coma after cardiopulmonary resuscitation: relation to seizures and myoclonus. Neurology 38:401-405
283. Fisher RS, Kaplan PW, Krumholz A, Lesser RP, Rosen SA, Wolff MR (1988) Failure of high-dose intravenous magnesium sulfate to control myoclonic status epilepticus. Clin Neuropharmacol 11:537-544
284. Williams A, Sekaninova S, Coakley J (1998) Suppression of elevated alanine aminotransferase activity in liver disease by vigabatrin. J Paediatr Child Health 34:395-397
285. Zaret BS, Beckner RR, Marini AM, Wagle W, Passarelli C (1982) Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction. Neurology 32:206-208
286. Moreiras Plaza M, Rodriguez Goyanes G, Cuina L, Alonso R (1999) On the toxicity of valproic-acid. Clin Nephrol 51:187-189
287. Hogg RJ, Sawyer M, Hecox K, Eigenbrodt E (1981) Carbamazepine-induced acute tubulointerstitial nephritis. J Pediatr 98:830-832
288. Varelas PN, Mirski MA (2001) Seizures in the adult intensive care unit. J Neurosurg Anesthesiol 13:163-175
289. Roberts C, French JA (2002) Anticonvulsants in acute medical illness. In: Delanty N (ed) Seizures. Medical causes and management. Humana Press, Inc, Totowa, NJ, pp 333-356
290. Shorvon S (1993) The drug treatment of epilepsy. In: Hopkins A, Shorvon S, Cascino G (eds) Epilepsy. Chapman and Hall, London, p 178
291. Leppik IE, Wolff DL (1993) Antiepileptic medication interactions. Neurol Clin 11:905-921